August 17, 2011

Perrigo is planning to launch more than 45 new products in fiscal 2012 that will translate into approximately $190 million added to annual Perrigo sales, Perrigo chairman, president and CEO Joe Papa told analysts during the company's fourth-quarter conference call Tuesday.

May 17, 2011

Perrigo on Monday announced that it has received final approval from the Food and Drug Administration for its abbreviated new drug application for over-the-counter ranitidine 150 (regular and cool mint), a generic version of Zantac 150.

July 31, 2007

The ECRM OTC & PBC report covers trends in bath and body, facial skin care, oral care, baby care, men's grooming, ethnic hair care, analgesics, digestives, allergy and health care, including product previews of Zantac mint tablets, Arnicare Gel, Airplus Ultra Arch, Traumeel and Murine Earigate.